NKGen Biotech Offers Clarification Regarding Quotation Display and Trading Status

Written by Emily J. Thompson, Senior Investment Analyst

NKGN%

Updated: Oct 09 2025

0mins

Company's Trading Status: NKGen Biotech clarified that the $0.00 stock price displayed on some financial websites does not reflect its actual value, but is due to limitations on public quote dissemination after moving to the OTC Expert Market due to filing compliance issues.
Regulatory Compliance Efforts: The company is actively working to regain compliance with reporting obligations under the Securities Exchange Act and has filed its Form 10-K for 2024, with plans to complete and file its Form 10-Qs for 2025 quarters.

About the author

Emily J. Thompson

Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.

NKGen Biotech Offers Clarification Regarding Quotation Display and Trading Status

About the author

Top News

Oil Firms Cautious on Venezuela Investment Push

GM Reports $7.1 Billion Charge Amid EV Shift

Stock Market Wraps 2025 with Double-Digit Gains

Novo Nordisk's Weight-Loss Pill Approval: Key Impacts

Related Articles

Chipotle vs Dutch Bros: Growth vs Valuation Showdown

XRP Drops 40% from July Peak; Ripple's Products Face Adoption Challenges

Sigh Up to Get Intellectia Insights

How did the company's recent strategic decisions impact its latest financial performance?

Can you explain the factors behind the recent changes in the company's stock price?

What are the expected impacts of current market trends on the company's future growth?

Based on the latest earnings report, what are the company's forecasted revenues for the next quarter?

How does the company's performance compare to its main competitors in the same sector?

People Also Watch